{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T14:57:04Z","timestamp":1775746624113,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T00:00:00Z","timestamp":1589760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T00:00:00Z","timestamp":1589760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1007\/s10741-020-09967-3","type":"journal-article","created":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T22:03:44Z","timestamp":1589839424000},"page":"869-877","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Maintenance immunosuppression in heart transplantation: insights from network meta-analysis of various immunosuppression regimens"],"prefix":"10.1007","volume":"27","author":[{"given":"Hiroki","family":"Ueyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiki","family":"Kuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisato","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulino","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabea","family":"Asleh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5740-9670","authenticated-orcid":false,"given":"Alexandros","family":"Briasoulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,18]]},"reference":[{"issue":"10","key":"9967_CR1","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.healun.2015.08.003","volume":"34","author":"LH Lund","year":"2015","unstructured":"Lund LH, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, Goldfarb S, Levvey BJ, Meiser B, Rossano JW, Yusen RD, Stehlik J (2015) The registry of the International Society for Heart and Lung Transplantation: thirty-second official adult heart transplantation report--2015; focus theme: early graft failure. J Heart Lung Transplant 34(10):1244\u20131254","journal-title":"J Heart Lung Transplant"},{"issue":"5","key":"9967_CR2","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1161\/CIRCULATIONAHA.111.040360","volume":"125","author":"Y Topilsky","year":"2012","unstructured":"Topilsky Y, Hasin T, Raichlin E, Boilson BA, Schirger JA, Pereira NL, Edwards BS, Clavell AL, Rodeheffer RJ, Frantz RP, Maltais S, Park SJ, Daly RC, Lerman A, Kushwaha SS (2012) Sirolimus as primary immunosuppression attenuates allograft vasculopathy with improved late survival and decreased cardiac events after cardiac transplantation. Circulation. 125(5):708\u2013720","journal-title":"Circulation."},{"issue":"6","key":"9967_CR3","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.jacc.2017.12.005","volume":"71","author":"R Asleh","year":"2018","unstructured":"Asleh R, Briasoulis A, Kremers WK, Adigun R, Boilson BA, Pereira NL, Edwards BS, Clavell AL, Schirger JA, Rodeheffer RJ, Frantz RP, Joyce LD, Maltais S, Stulak JM, Daly RC, Tilford J, Choi WG, Lerman A, Kushwaha SS (2018) Long-term sirolimus for primary immunosuppression in heart transplant recipients. J Am Coll Cardiol 71(6):636\u2013650","journal-title":"J Am Coll Cardiol"},{"key":"9967_CR4","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","volume":"62","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62:e1\u2013e34","journal-title":"J Clin Epidemiol"},{"key":"9967_CR5","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA (2011) The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. Bmj 343:d5928","journal-title":"Bmj"},{"key":"9967_CR6","doi-asserted-by":"publisher","first-page":"e115065","DOI":"10.1371\/journal.pone.0115065","volume":"9","author":"B Neupane","year":"2014","unstructured":"Neupane B, Richer D, Bonner AJ, Kibret T, Beyene J (2014) Network meta-analysis using R: a review of currently available automated packages. PLoS One 9:e115065","journal-title":"PLoS One"},{"key":"9967_CR7","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. Bmj 327:557\u2013560","journal-title":"Bmj"},{"key":"9967_CR8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12874-015-0060-8","volume":"15","author":"G Rucker","year":"2015","unstructured":"Rucker G, Schwarzer G (2015) Ranking treatments in frequentist network meta-analysis works without resampling methods. BMC Med Res Methodol 15:58","journal-title":"BMC Med Res Methodol"},{"key":"9967_CR9","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1111\/ajt.13588","volume":"16","author":"AK Andreassen","year":"2016","unstructured":"Andreassen AK, Andersson B, Gustafsson F, Eiskjaer H, Radegran G, Gude E, Jansson K, Solbu D, Karason K, Arora S, Dellgren G, Gullestad L (2016) Everolimus initiation with early calcineurin inhibitor withdrawal in de novo heart transplant recipients: three-year results from the randomized SCHEDULE study. Am J Transplant 16:1238\u20131247","journal-title":"Am J Transplant"},{"key":"9967_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/TP.0b013e31822057f1","volume":"92","author":"S Arora","year":"2011","unstructured":"Arora S, Ueland T, Wennerblom B, Sigurdadottir V, Eiskjaer H, Botker HE, Ekmehag B, Jansson K, Mortensen SA, Saunamaki K, Simonsen S, Gude E, Bendz B, Solbu D, Aukrust P, Gullestad L (2011) Effect of everolimus introduction on cardiac allograft vasculopathy--results of a randomized, multicenter trial. Transplantation 92:235\u2013243","journal-title":"Transplantation"},{"key":"9967_CR11","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1016\/j.transproceed.2013.03.032","volume":"45","author":"C Bara","year":"2013","unstructured":"Bara C, Dengler T, Hack MA, Ladenburger S, Lehmkuhl HB (2013) A 1-year randomized controlled study of everolimus versus mycophenolate mofetil with reduced-dose cyclosporine in maintenance heart transplant recipients. Transplant Proc 45:2387\u20132392","journal-title":"Transplant Proc"},{"key":"9967_CR12","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1111\/ajt.12181","volume":"13","author":"HJ Eisen","year":"2013","unstructured":"Eisen HJ, Kobashigawa J, Starling RC, Pauly DF, Kfoury A, Ross H, Wang SS, Cantin B, Van Bakel A, Ewald G, Hirt S, Lehmkuhl H, Keogh A, Rinaldi M, Potena L, Zuckermann A, Dong G, Cornu-Artis C, Lopez P (2013) Everolimus versus mycophenolate mofetil in heart transplantation: a randomized, multicenter trial. Am J Transplant 13:1203\u20131216","journal-title":"Am J Transplant"},{"key":"9967_CR13","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1111\/j.1600-6143.2006.01527.x","volume":"6","author":"CA Gleissner","year":"2006","unstructured":"Gleissner CA, Doesch A, Ehlermann P, Koch A, Sack FU, Katus HA, Dengler TJ (2006) Cyclosporine withdrawal improves renal function in heart transplant patients on reduced-dose cyclosporine therapy. Am J Transplant 6:2750\u20132758","journal-title":"Am J Transplant"},{"key":"9967_CR14","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1097\/TP.0b013e3181963371","volume":"87","author":"J Groetzner","year":"2009","unstructured":"Groetzner J, Kaczmarek I, Schulz U, Stegemann E, Kaiser K, Wittwer T, Schirmer J, Voss M, Strauch J, Wahlers T, Sohn HY, Wagner F, Tenderich G, Stempfle HU, Mueller-Ehmsen J, Schmid C, Vogeser M, Koch KC, Reichenspurner H, Daebritz S, Meiser B, Reichart B (2009) Mycophenolate and sirolimus as calcineurin inhibitor-free immunosuppression improves renal function better than calcineurin inhibitor-reduction in late cardiac transplant recipients with chronic renal failure. Transplantation 87:726\u2013733","journal-title":"Transplantation"},{"key":"9967_CR15","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.healun.2014.11.025","volume":"34","author":"S Guethoff","year":"2015","unstructured":"Guethoff S, Stroeh K, Grinninger C, Koenig MA, Kleinert EC, Rieger A, Mayr T, von Ziegler F, Reichart B, Hagl C, Schramm R, Kaczmarek I, Meiser BM (2015) De novo sirolimus with low-dose tacrolimus versus full-dose tacrolimus with mycophenolate mofetil after heart transplantation--8-year results. J Heart Lung Transplant 34:634\u2013642","journal-title":"J Heart Lung Transplant"},{"key":"9967_CR16","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1097\/TP.0b013e3181fd01b7","volume":"90","author":"L Gullestad","year":"2010","unstructured":"Gullestad L, Mortensen SA, Eiskjaer H, Riise GC, Mared L, Bjortuft O, Ekmehag B, Jansson K, Simonsen S, Gude E, Rundqvist B, Fagertun HE, Solbu D, Iversen M (2010) Two-year outcomes in thoracic transplant recipients after conversion to everolimus with reduced calcineurin inhibitor within a multicenter, open-label, randomized trial. Transplantation 90:1581\u20131589","journal-title":"Transplantation"},{"key":"9967_CR17","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1161\/01.CIR.0000136812.90177.94","volume":"110","author":"A Keogh","year":"2004","unstructured":"Keogh A, Richardson M, Ruygrok P, Spratt P, Galbraith A, O'Driscoll G, Macdonald P, Esmore D, Muller D, Faddy S (2004) Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial. Circulation 110:2694\u20132700","journal-title":"Circulation"},{"key":"9967_CR18","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/TP.0b013e3181aacd22","volume":"88","author":"HB Lehmkuhl","year":"2009","unstructured":"Lehmkuhl HB, Arizon J, Vigano M, Almenar L, Gerosa G, Maccherini M, Varnous S, Musumeci F, Hexham JM, Mange KC, Livi U (2009) Everolimus with reduced cyclosporine versus MMF with standard cyclosporine in de novo heart transplant recipients. Transplantation 88:115\u2013122","journal-title":"Transplantation"},{"key":"9967_CR19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1161\/01.CIR.0000070421.38604.2B","volume":"108","author":"D Mancini","year":"2003","unstructured":"Mancini D, Pinney S, Burkhoff D, LaManca J, Itescu S, Burke E, Edwards N, Oz M, Marks AR (2003) Use of rapamycin slows progression of cardiac transplantation vasculopathy. Circulation 108:48\u201353","journal-title":"Circulation"},{"key":"9967_CR20","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.healun.2007.03.005","volume":"26","author":"M Vigano","year":"2007","unstructured":"Vigano M, Tuzcu M, Benza R, Boissonnat P, Haverich A, Hill J, Laufer G, Love R, Parameshwar J, Pulpon LA, Renlund D, Abeywickrama K, Cretin N, Starling RC, Eisen HJ (2007) Prevention of acute rejection and allograft vasculopathy by everolimus in cardiac transplants recipients: a 24-month analysis. J Heart Lung Transplant 26:584\u2013592","journal-title":"J Heart Lung Transplant"},{"key":"9967_CR21","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1177\/1060028014527723","volume":"48","author":"M White","year":"2014","unstructured":"White M, Boucher A, Dandavino R, Fortier A, Pelletier GB, Racine N, Ducharme A, de Denus S, Carrier M, Collette S (2014) Sirolimus immunoprophylaxis and renal histological changes in long-term cardiac transplant recipients: a pilot study. Ann Pharmacother 48:837\u2013846","journal-title":"Ann Pharmacother"},{"key":"9967_CR22","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1111\/j.1600-6143.2012.04131.x","volume":"12","author":"A Zuckermann","year":"2012","unstructured":"Zuckermann A, Keogh A, Crespo-Leiro MG, Mancini D, Vilchez FG, Almenar L, Brozena S, Eisen H, Tai SS, Kushwaha S (2012) Randomized controlled trial of sirolimus conversion in cardiac transplant recipients with renal insufficiency. Am J Transplant 12:2487\u20132497","journal-title":"Am J Transplant"},{"key":"9967_CR23","doi-asserted-by":"publisher","unstructured":"Barten MJ, Hirt SW, Garbade J, Bara C, Doesch AO, Knosalla C, Grinninger C, Stypmann J, Sieder C, Lehmkuhl HB, Porstner M, Schulz U (2019) Comparing everolimus-based immunosuppression with reduction or withdrawal of calcineurin inhibitor reduction from six months after heart transplantation: the randomized MANDELA study. Am J Transplant 18. https:\/\/doi.org\/10.1111\/ajt.15361","DOI":"10.1111\/ajt.15361"},{"issue":"11","key":"9967_CR24","doi-asserted-by":"publisher","first-page":"H1646","DOI":"10.1152\/ajpheart.00365.2013","volume":"305","author":"S K\u00f6nig","year":"2013","unstructured":"K\u00f6nig S, Browne S, Doleschal B, Schernthaner M, Poteser M, M\u00e4chler H, Wittchow E, Braune M, Muik M, Romanin C, Groschner K (2013) Inhibition of orai1-mediated Ca(2+) entry is a key mechanism of the antiproliferative action of sirolimus in human arterial smooth muscle. Am J Physiol Heart Circ Physiol 305(11):H1646\u2013H1657","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"9967_CR25","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.healun.2012.11.028","volume":"32","author":"I Kaczmarek","year":"2013","unstructured":"Kaczmarek I, Zaruba MM, Beiras-Fernandez A, Reimann R, Nickel T, Grinninger C, Sadoni S, Hagl C, Meiser B (2013) Tacrolimus with mycophenolate mofetil or sirolimus compared with calcineurin inhibitor-free immunosuppression (sirolimus\/mycophenolate mofetil) after heart transplantation: 5-year results. J Heart Lung Transplant 32(3):277\u2013284","journal-title":"J Heart Lung Transplant"},{"issue":"3","key":"9967_CR26","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/j.1524-475X.2007.00232.x","volume":"15","author":"M Zakliczynski","year":"2007","unstructured":"Zakliczynski M, Nozynski J, Kocher A, Lizak MK, Zakliczynska H, Przybylski R, Wojarski J, Zembala M (2007) Surgical wound-healing complications in heart transplant recipients treated with rapamycin. Wound Repair Regen 15(3):316\u2013321","journal-title":"Wound Repair Regen"},{"issue":"9","key":"9967_CR27","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.healun.2006.05.013","volume":"25","author":"JF Delgado","year":"2006","unstructured":"Delgado JF, Torres J, Jos\u00e9Ruiz-Cano M, S\u00e1nchez V, Escribano P, Borruel S, Mar\u00eda Cortina J, de la Calzada CS (2006) Sirolimus-associated interstitial pneumonitis in 3 heart transplant recipients. J Heart Lung Transplant 25(9):1171\u20131174","journal-title":"J Heart Lung Transplant"},{"issue":"11","key":"9967_CR28","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.healun.2018.07.004","volume":"37","author":"R Asleh","year":"2018","unstructured":"Asleh R, Briasoulis A, Pereira NL, Edwards BS, Frantz RP, Daly RC, Lerman A, Kushwaha SS (2018) Hypercholesterolemia after conversion to sirolimus as primary immunosuppression and cardiac allograft vasculopathy in heart transplant recipients. J Heart Lung Transplant 37(11):1372\u20131380","journal-title":"J Heart Lung Transplant"},{"issue":"21","key":"9967_CR29","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.1016\/j.jacc.2019.03.499","volume":"73","author":"R Asleh","year":"2019","unstructured":"Asleh R, Clavell AL, Pereira NL, Smith B, Briasoulis A, Alnsasra H, Kremers WK, Habermann TM, Otley CC, Li X, Edwards BS, Stulak JM, Daly RC, Kushwaha SS (2019) Incidence of malignancies in patients treated with sirolimus following heart transplantation. J Am Coll Cardiol 73(21):2676\u20132688","journal-title":"J Am Coll Cardiol"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-020-09967-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-020-09967-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-020-09967-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T23:04:10Z","timestamp":1650668650000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-020-09967-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,18]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["9967"],"URL":"https:\/\/doi.org\/10.1007\/s10741-020-09967-3","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,18]]},"assertion":[{"value":"18 May 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}